Canada · Delayed Price · Currency is CAD Aptose Biosciences Statistics
Total Valuation
TSX:APS has a market cap or net worth of CAD 5.67 million. The enterprise value is 31.30 million.
| Market Cap | 5.67M |
| Enterprise Value | 31.30M |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:APS has 2.55 million shares outstanding. The number of shares has increased by 349.80% in one year.
| Current Share Class | 2.55M |
| Shares Outstanding | 2.55M |
| Shares Change (YoY) | +349.80% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.26% |
| Owned by Institutions (%) | 3.91% |
| Float | 2.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.16 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.93 |
Financial Position
The company has a current ratio of 0.53
| Current Ratio | 0.53 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.79 |
| Interest Coverage | -31.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -141.01% |
| Return on Invested Capital (ROIC) | -2,110.27% |
| Return on Capital Employed (ROCE) | 2,639.84% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.07M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.33% in the last 52 weeks. The beta is 0.60, so TSX:APS's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -75.33% |
| 50-Day Moving Average | 2.16 |
| 200-Day Moving Average | 2.18 |
| Relative Strength Index (RSI) | 55.37 |
| Average Volume (20 Days) | 6,117 |
Short Selling Information
The latest short interest is 6,975, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 6,975 |
| Short Previous Month | 10,084 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -27.14M |
| Pretax Income | -26.87M |
| Net Income | -26.87M |
| EBITDA | -27.11M |
| EBIT | -27.14M |
| Earnings Per Share (EPS) | -12.77 |
Balance Sheet
The company has 853,842 in cash and 26.49 million in debt, with a net cash position of -25.63 million or -10.04 per share.
| Cash & Cash Equivalents | 853,842 |
| Total Debt | 26.49M |
| Net Cash | -25.63M |
| Net Cash Per Share | -10.04 |
| Equity (Book Value) | -27.09M |
| Book Value Per Share | -10.61 |
| Working Capital | -4.60M |
Cash Flow
In the last 12 months, operating cash flow was -33.72 million and capital expenditures -6,964, giving a free cash flow of -33.73 million.
| Operating Cash Flow | -33.72M |
| Capital Expenditures | -6,964 |
| Free Cash Flow | -33.73M |
| FCF Per Share | -13.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:APS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -349.80% |
| Shareholder Yield | -349.80% |
| Earnings Yield | -474.28% |
| FCF Yield | -595.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 26, 2025. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | Feb 26, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |